AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

XBiotech Inc. Director's Dealing 2020

Aug 26, 2020

34229_dirs_2020-08-26_8d675241-c9ad-430f-b7c8-5c7a2136e50b.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2020-08-24

Reporting Person: HAN QUEENA (VP Finance & HR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-24	Common Shares	M	18700	$7.50	Acquired	18700	Direct
2020-08-24	Common Shares	S	18700	$19.6543	Disposed	0	Direct
2020-08-24	Common Shares	M	5000	$15.00	Acquired	5000	Direct
2020-08-24	Common Shares	S	5000	$19.6543	Disposed	0	Direct
2020-08-24	Common Shares	M	12308	$4.16	Acquired	12308	Direct
2020-08-24	Common Shares	S	12308	$19.6543	Disposed	0	Direct
2020-08-24	Common Shares	M	3333	$4.14	Acquired	3333	Direct
2020-08-24	Common Shares	S	3333	$19.6543	Disposed	0	Direct
2020-08-24	Common Shares	M	12500	$5.26	Acquired	12500	Direct
2020-08-24	Common Shares	S	12500	$19.6543	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-24	Stock options	$7.50	M	18700	Disposed	2021-02-28	Common Stocks (18700)	Direct
2020-08-24	Stock Options	$15.00	M	5000	Disposed	2022-12-12	Common Stocks (5000)	Direct
2020-08-24	Stock Options	$4.16	M	12308	Disposed	2028-05-08	Common Stocks (12308)	Direct
2020-08-24	Stock Options	$4.14	M	3333	Disposed	2028-12-07	Common Stocks (3333)	Direct
2020-08-24	Stock Options	$5.26	M	12500	Disposed	2029-01-04	Common Stocks (12500)	Direct